Combination of a DPP IV inhibitor and a cardiovascular compound

Details for Australian Patent Application No. 2003242593 (hide)

Owner NOVARTIS AG

Inventors Holmes, David Grenville; Hughes, Thomas Edward; Shetty, Suraj Shivappa

Agent Davies Collison Cave

Pub. Number AU-A-2003242593

PCT Number PCT/EP03/05639

PCT Pub. Number WO2003/099279

Priority 0212412.1 29.05.02 GB

Filing date 28 May 2003

Wipo publication date 12 December 2003

International Classifications

A61K 031/454

A61K 031/40 - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 031/16 - Amides, e.g. hydroxamic acids

A61P 003/10 Drugs for disorders of the metabolism

A61K 031/41 - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 0212412.1 29.05.02 GB

5 February 2004 Application Open to Public Inspection

  Published as AU-A-2003242593

2 August 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003242594-GAME CONTROLLER FOR MOBILE TELECOMMUNICATION TERMINALS

2003242592-AMIDE DERIVATIVES AS INHIBITORS OF THE ENZYMATIC ACTIVITY OF RENIN